Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncogene. 2007 Oct 25;26(49):6968-78. Epub 2007 May 7.

Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.

Author information

1
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.

Abstract

Several distinct mutations within the kinase domain of the epidermal growth factor receptor (EGFR) are associated with non-small cell lung cancer, but mechanisms underlying their oncogenic potential are incompletely understood. Although normally ligand-induced kinase activation targets EGFR to Cbl-mediated receptor ubiquitinylation and subsequent degradation in lysosomes, we report that certain EGFR mutants escape this regulation. Defective endocytosis characterizes a deletion mutant of EGFR, as well as a point mutant (L858R-EGFR), whose association with c-Cbl and ubiquitinylation are impaired. Our data raise the possibility that refractoriness of L858R-EGFR to downregulation is due to enhanced heterodimerization with the oncogene product HER2, which leads to persistent stimulation.

PMID:
17486068
DOI:
10.1038/sj.onc.1210503
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center